JPMorgan lowered the firm’s price target on Doximity (DOCS) to $60 from $63 and keeps a Neutral rating on the shares. The firm updated the company’s model.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Doximity call volume above normal and directionally bullish
- Doximity price target lowered to $50 from $80 at Goldman Sachs
- Doximity price target lowered to $65 from $87 at Baird
- Doximity’s Stock Decline Offers a Compelling Buy Opportunity Amid Strong Performance and Growth Potential
- Doximity’s Earnings Call: Strong Growth Amid Caution